These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22422928)
1. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation. Kistler CE; Goldstein AO Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928 [No Abstract] [Full Text] [Related]
2. Varenicline for smoking cessation. Harrison-Woolrych M BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037 [No Abstract] [Full Text] [Related]
3. In brief: Cardiovascular safety of varenicline (Chantix). Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367 [No Abstract] [Full Text] [Related]
4. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials. Ware JH; Vetrovec GW; Miller AB; Van Tosh A; Gaffney M; Yunis C; Arteaga C; Borer JS Am J Ther; 2013; 20(3):235-46. PubMed ID: 23615317 [TBL] [Abstract][Full Text] [Related]
5. More evidence that varenicline harms the heart. Harv Ment Health Lett; 2011 Oct; 28(4):7. PubMed ID: 22125830 [No Abstract] [Full Text] [Related]
6. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Toh S; Baker MA; Brown JS; Kornegay C; Platt R; JAMA Intern Med; 2013 May; 173(9):817-9. PubMed ID: 23529063 [No Abstract] [Full Text] [Related]
8. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study. Graham DJ; By K; McKean S; Mosholder A; Kornegay C; Racoosin JA; Young J; Levenson M; MaCurdy TE; Worrall C; Kelman JA Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1205-12. PubMed ID: 25044169 [TBL] [Abstract][Full Text] [Related]
9. Varenicline (Chantix) warnings: risk versus benefit. Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873 [No Abstract] [Full Text] [Related]
10. Safety of varenicline in patients with cardiovascular disease. Haber SL; Boomershine V; Raney E J Pharm Pract; 2014 Feb; 27(1):65-70. PubMed ID: 24080536 [TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo. Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286 [TBL] [Abstract][Full Text] [Related]
14. A case of late-life onset mania during Varenicline assisted smoking cessation. Francois D; Odom A; Kotbi N Int J Geriatr Psychiatry; 2011 Jun; 26(6):658-9. PubMed ID: 21480382 [No Abstract] [Full Text] [Related]
15. Varenicline and the evaluation of neuropsychiatric adverse events in smokers. O'Malley SS Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436 [No Abstract] [Full Text] [Related]
16. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects! Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119 [No Abstract] [Full Text] [Related]
17. Varenicline for smoking cessation: is it a heartbreaker? Hays JT CMAJ; 2011 Sep; 183(12):1346-7. PubMed ID: 21727229 [No Abstract] [Full Text] [Related]
18. Practical implementation of varenicline as an aid to smoking cessation in clinical practice. Tonstad S Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313 [TBL] [Abstract][Full Text] [Related]
19. [Effectiveness and safety of varenicline for smoking cessation]. Christalla P; Dewenter M; El-Armouche A Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478 [TBL] [Abstract][Full Text] [Related]